Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis

PLoS Pathogens

Volumn 5, Issue 11, 2009, Pages

  Kesley Robertson, D ^a   Gu, Ling ^a   Rowe, Regina K ^a   Beatty, Wandy L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN;

ARTICLE; BACTERIAL MEMBRANE; BACTERIAL REPRODUCTION; BACTERIUM IDENTIFICATION; BIOGENESIS; BIOSYNTHESIS; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; GOLGI COMPLEX; HOST CELL; HUMAN; HUMAN CELL; MYELIN DEFICIENCY; PERSISTENT INFECTION; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN TRANSPORT; ANIMAL; CHO CELL; CRICETULUS; HAMSTER; HOST PATHOGEN INTERACTION; INTRACELLULAR MEMBRANE; METABOLISM; MULTIVESICULAR BODY; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; CHLAMYDIAE; EUKARYOTA;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHO CELLS; CRICETINAE; CRICETULUS; GOLGI APPARATUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR MEMBRANES; MULTIVESICULAR BODIES; SPHINGOLIPIDS; SPHINGOMYELINS;

EID: 73549115436     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000664     Document Type: Article

References (36)

1. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181 Suppl 3: S402-410.
2. Schachter J (1988) In: Barron AL, ed.Microbiology of Chlamydia. CRC Press: Boca Raton. pp 153-165.
3. Beatty WL, Morrison RP, Byrne GI (1994) Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58: 686-699.
4. Beatty WL, Byrne GI, Morrison RP (1994) Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 2: 94-98.
5. McClarty G (1994) Chlamydiae and the biochemistry of intracellular parasitism. Trends in Microbiology 2: 157-164.
6. Newhall WJ (1998) In: Microbiology of Chlamydia. Barron AL, ed. CRC Press: Boca Raton. pp 47-70.
7. Wylie JL, Hatch GM, McClarty G (1997) Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol 179: 7233-7242.
8. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH (2008) Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 105: 9379-9384.
9. Kumar Y, Cocchiaro J, Valdivia RH (2006) The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 16: 1646-1651.
10. van Ooij C, Kalman L, van Ijzendoorn S, Nishijima M, Hanada K, et al. (2000) Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell Microbiol 2: 627-637.
11. Carabeo RA, Mead DJ, Hackstadt T (2003) Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci U S A 100:6771-6776.
12. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA (1996) Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO Journal 15: 964-977.
13. Hackstadt T, Scidmore MA, Rockey DD (1995) Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92: 4877-4881.
14. Beatty WL (2006) Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J Cell Sci 119: 350-359.
15. Beatty WL (2008) Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect Immun 76: 2872-2881.
16. Hanada K, Nishijima M, Fujita T, Kobayashi S (2000) Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant. Biochem Pharmacol 59: 1211-1216.
17. Hanada K, Hara T, Fukasawa M, Yamaji A, Umeda M, et al. (1998) Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem 273: 33787-33794.
18. Hanada K, Nishijima M, Kiso M, Hasegawa A, Fujita S, et al. (1992) Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. J Biol Chem 267: 23527-23533.
19. Ridderhof JC, Barnes RC (1989) Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis. Infect Immun 57: 3189-3193.
20. Beatty WL, Byrne GI, Morrison RP (1993) Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A 90: 3998-4002.
21. Morrison RP (2000) Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect Immun 68: 6038-6040.
22. Weiss E (1950) The effect of antibiotics on agents of the psittacosis-lymphogranuloma group. I. The effect of penicillin. J Infect Dis 87: 249-263.
23. Matsumoto A, Manire GP (1970) Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 101:278-285.
24. Saenz JB, Sun WJ, Chang JW, Li J, Bursulaya B, et al. (2009) Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol 5: 157-165.
25. Klausner RD, Donaldson JG, Lippincott-Schwartz J (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116:1071-1080.
26. Higgins ME, Davies JP, Chen FW, Ioannou YA (2001) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Gen Metabol 68: 1-13.
27. Kobayashi T, Beuchat MH, Lindsay M, Frias S, Palmiter RD, et al. (1999) Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1: 113-118.
28. Kobayashi T, Vischer UM, Rosnoblet C, Lebrand C, Lindsay M, et al. (2000) The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11: 1829-1843.
29. Kumar Y, Valdivia RH (2008) Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4: 159-169.
30. Moulder JW (1991) Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55: 143-190.
31. Bavoil PM, Hsia RC (1998) Type III secretion in Chlamydia: a case of deja vu? Mol Microbiol 28: 860-862.
32. Wilson DP, Timms P, McElwain DL, Bavoil PM (2006) Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull Math Biol 68: 161-178.
33. Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA (1997) Origins and functions of the chlamydial inclusion. Trends Microbiol 5: 288-293.
34. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER (1999) The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1: 119-130.
35. Fields KA, Fischer E, Hackstadt T (2002) Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect Immun 70: 3816-3823.
36. Caldwell HD, Kromhout J, Schachter J (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31: 1161-1176.